Continuous activation of the ERK MAPK signaling pathway can promote the transformation of normal cells into tumors, while inhibition of the ERK MAPK signaling pathway can inhibit tumor growth in vivo [66]. The gene discussed is MAPK1; the disease is neoplasm.